News – Page 12 – Asian Fund for Cancer Research

How cancer drugs find their targets could lead to a new toolset for drug development

05/07/2020Global Cancer News

In the watery inside of a cell, complex processes take place in tiny functional compartments called organelles. These compartments are bound by thin membranes. But in the past few years, research at Whitehead Institute and elsewhere has shown that there are other…

6 Safety Tips for Flying During COVID-19 Summer

01/07/2020AFCR News, Coronavirus

Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board The phased reopening in many states provides an opportunity to release the frustrations built up after staying-at-home for months. As summer begins, people are planning to take vacations, and many of them are…

Yale Journal of Biology and Medicine Interview with Head of AFCR-Supported Translational Cancer Research Project

30/06/2020AFCR News

We have completed six studies in the US and now we are doing an international clinical trial with a target population of hepatocellular carcinoma, which is the major type of liver cancer in Asia... Read more: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309656/

10 Ways Your Diet Can Reduce Your Cancer Risk

28/06/2020AFCR News

A healthy diet can impact many areas of health. A poor diet can increase the risk of the six most common types of cancer worldwide. There are many different sources telling many different stories about what a healthy diet and lifestyle look…

Personal Discipline and Perseverance Are Still the Best Practice to Prevent COVID-19 in 2020 Amid the Uncertainty of Protective Vaccine Availability

19/06/2020AFCR News, Coronavirus

Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board Excitement spread quickly after a June 14 report that a COVID-19 vaccine developed by Imperial College London in the U.K. will be tested in humans. What excites people is that the vaccine, which…

Will This Drug Relight the Dimming Hope of Finding Effective Therapies for COVID-19?

06/06/2020AFCR News, Coronavirus

Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board Many people were disappointed by recent high-profile clinical trial results on Remdesivir, the drug that people had put high hopes on as the best candidate for an effective COVID-19 treatment. A report published in…

Can Vaccines Win the Race Against the Novel Coronavirus?

01/06/2020AFCR News, Coronavirus

Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board The U.S. death toll has passed the 100,000 mark this week, but effective anti-viral drugs are still not available for the treatment of COVID-19. Rather, many people have been putting their hope on…

Don’t Ignore These Ovarian Cancer Related Symptoms

26/05/2020AFCR News, Awareness, Cancer Types & Facts

Often known as “the silent killer”, ovarian cancer is difficult to detect early because the ovaries are deep within the pelvis and initial symptoms are often ambiguous and non-specific. Too often the cancer goes undiagnosed until after the disease is far advanced…

Better Treatment Is on the Way as Doctors Know More about the Tricks of Novel Coronavirus

22/05/2020AFCR News, Coronavirus

Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board On February 11, weeks into the COVID-19 outbreak, the novel coronavirus was officially called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as most patients showed mild to severe respiratory illness. Doctors shared the…

AACR Virtual Annual Meeting I presents new data on cancer biology, treatment, screening, risk reduction

16/05/2020Global Cancer News

Brief points covered in the America Association for Cancer Research (AACR) Virtual Annual Meeting I held on April 27-28th: -Treating BRAF-Positive Melanoma by adding checkpoint inhibitor Tecentriq (atezolizumab) to a combination of two targeted drugs Zelboraf (vemurafenib) and Cotellic (cobimetinib) -PARP Inhibitor (targeted drugs…